Page 145 - 《中国药房》2025年17期
P. 145

态；可通过多靶点协同作用发挥选择性抗肿瘤效应；可                           [10]  LIU C L，CHIU Y T，HU M L. Fucoxanthin enhances HO-1
          通过调控肠道菌群、β3ADR/UCP-1信号通路等发挥抗肥                           and NQO1 expression in murine hepatic BNL CL.2 cells
          胖作用。另外，岩藻黄素的特征性官能团具有良好的靶                                through activation of the Nrf2/ARE system partially by its
          点选择性和可逆抑制活性，是新型药物设计开发的                                  pro-oxidant  activity[J].  J  Agric  Food  Chem，2011，59
          模板。                                                    （20）：11344-11351.
              目前，岩藻黄素在药理学、毒理学和药剂学领域已                         [11]  DING  R，ZHONG  S Y，DENG  L Y，et  al.  Fucoxanthin
                                                                  prevents lipopolysaccharide-induced acute lung injury by
          有相关研究文献发表，然而该成分的产业化、商业化开
                                                                  inhibiting  ferroptosis  via  Nrf2/STAT3  and  glutathione
          发仍处于起步阶段 ，这可能与岩藻黄素的性能研究不
                          [39]
                                                                  pathways[J]. Am J Chin Med，2024，52（6）：1773-1794.
          足以及生产工艺开发中遇到的难题（如生产工艺成本
                                                             [12]  FILHO A  M，LAVERSANNE  M，FERLAY  J，et  al. The
          高、绿色可持续性低）有关。已有研究在硅藻中探索岩
                                                                  GLOBOCAN  2022  cancer  estimates：data  sources，me-
                          [40]
          藻黄素的合成路径 ，未来或可通过生物合成技术，解
                                                                  thods，and a snapshot of the cancer burden worldwide[J].
          决岩藻黄素的生产难题。
                                                                  Int J Cancer，2025，156（7）：1336-1346.
          参考文献
                                                             [13]  MÉRESSE S，FODIL M，FLEURY F，et al. Fucoxanthin，
          [ 1 ]  HOSOKAWA M. Molecular nutritional research for effec‐
                                                                  a marine-derived carotenoid from brown seaweeds and mi‐
              tive  utilization  of  marine  lipid-soluble  components[J].  J
                                                                  croalgae：a  promising  bioactive  compound  for  cancer
              Oleo Sci，2025，74（4）：329-340.
                                                                  therapy[J]. Int J Mol Sci，2020，21（23）：9273.
          [ 2 ]  任祥雨，郑佳文，田笑笑，等. 岩藻黄素对小鼠非酒精性
                                                             [14]  SALAMI M，SALAMI R，AARABI M H，et al. Targeting
              脂肪性肝病的修复作用[J]. 食品科学，2024，45（3）：
                                                                  glioma cells with nutraceuticals：therapeutic effects based
              42-52.
                                                                  on molecular mechanisms，new evidence and perspectives
          [ 3 ]  YANG S，LI J，YAN L，et al. Molecular mechanisms of fu‐
                                                                  [J]. Mini Rev Med Chem，2023，23（11）：1167-1192.
              coxanthin in alleviating lipid deposition in metabolic asso‐
                                                             [15]  JIN Y，QIU S，SHAO N，et al. Fucoxanthin and tumor ne‐
              ciated fatty liver disease[J]. J Agric Food Chem，2024，72
                                                                  crosis  factor-related  apoptosis-inducing  ligand （TRAIL）
              （18）：10391-10405.
                                                                  synergistically promotes apoptosis of human cervical can‐
          [ 4 ]  KIM  M  B，BAE  M，LEE Y，et  al.  Consumption  of  low
                                                                  cer cells by targeting PI3K/Akt/NF-κB signaling pathway
              dose fucoxanthin does not prevent hepatic and adipose in‐
                                                                  [J]. Med Sci Monit，2018，24：11-18.
              flammation and fibrosis in mouse models of diet-induced
                                                             [16]  LONG Y，CAO X B，ZHAO R Q，et al. Fucoxanthin treat‐
              obesity[J]. Nutrients，2022，14（11）：2280.
                                                                  ment inhibits nasopharyngeal carcinoma cell proliferation
          [ 5 ]  LIANG D，LIU C Y，LI Y，et al. Engineering fucoxanthin-
                                                                  through  induction  of  autophagy  mechanism[J].  Environ
              loaded probiotics’ membrane vesicles for the dietary inter‐
                                                                  Toxicol，2020，35（10）：1082-1090.
              vention of colitis[J]. Biomaterials，2023，297：122107.
                                                             [17]  YU R X，YU R T，LIU Z. Inhibition of two gastric cancer
          [ 6 ]  SUN X W，ZHAO H L，LIU Z L，et al. Modulation of gut
                                                                  cell lines induced by fucoxanthin involves downregulation
              microbiota by fucoxanthin during alleviation of obesity in
                                                                  of Mcl-1 and STAT3[J]. Hum Cell，2018，31（1）：50-63.
              high-fat  diet-fed  mice[J].  J Agric  Food  Chem，2020，68
              （18）：5118-5128.                                [18]  WANG J，DONG X，LI D，et al. Fucoxanthin inhibits gas‐
          [ 7 ]  MA J J，YUE S M，LIU Y H，et al. Fucoxanthin amelio‐  tric  cancer  lymphangiogenesis  and  metastasis  by  regula-
              rates ulcerative colitis by maintaining the epithelial barrier   ting Ran expression[J]. Phytomedicine，2023，118：154926.
              via  blocking  JAK2/STAT3  signaling  pathway[J].  Toxicol   [19]  ABIDOV M，RAMAZANOV Z，SEIFULLA R，et al. The
              Appl Pharmacol，2025，495：117213.                     effects of Xanthigen in the weight management of obese
          [ 8 ]  YANG X J，GUO G，DANG M Y，et al. Assessment of the   premenopausal  women  with  non-alcoholic  fatty  liver
              therapeutic  effects  of  fucoxanthin  by  attenuating  inflam‐  disease  and  normal  liver  fat[J].  Diabetes  Obes  Metab，
              mation  in  ovalbumin-induced  asthma  in  an  experimental   2010，12（1）：72-81.
              animal model[J]. J Environ Pathol Toxicol Oncol，2019，38  [20]  HITOE  S，SHIMODA  H.  Seaweed  fucoxanthin  supple‐
              （3）：229-238.                                        mentation  improves  obesity  parameters  in  mild  obese
          [ 9 ]  RAJI V，LOGANATHAN C，RAMESH T，et al. Dual anti‐   Japanese  subjects[J].  Funct  Foods  Health  Dis，2017，7
              diabetic and antihypertensive activity of fucoxanthin iso‐  （4）：246.
              lated  from  Sargassum  wightii  Greville  in  vivo  rat  model  [21]  KAWEE-AI A，KIM A T，KIM S M. Inhibitory activities
              [J]. Food Sci Hum Wellness，2023，12（5）：1693-1700.    of  microalgal  fucoxanthin  against  α -amylase，α -glucosi‐


          中国药房  2025年第36卷第17期                                              China Pharmacy  2025 Vol. 36  No. 17    · 2219 ·
   140   141   142   143   144   145   146   147   148